CellaVision AB: Zlatko Rihter leaves his position as CEO at CellaVision AB
The information was released for public disclosure on May 29, 2020, at 08:20 CET
CellaVision's President and CEO, Zlatko Rihter, has informed the Board of Directors that he wishes to resign as CEO of the company in order to take on the position as President and CEO of the medical technology company Mölnlycke Health Care AB. Zlatko Rihter has been CEO of CellaVision since January 1, 2015.
Zlatko will continue in his current role during the notice period and leave his assignment by November 28, 2020 at the latest. The Board has therefore initiating a recruitment process to find his successor.
“During his almost six years as CEO, Zlatko Rihter has very successfully developed CellaVision to the strong company we see today. CellaVision has fundamentally changed to a company with a completely different breadth in the customer offering and geographical presence resulting in completely different opportunities. Zlatko has consistently delivered, and the company's sales and earnings have almost tripled. Zlatko has a breadth in his leadership with a humility, a transparency and a rare ability to “get things done”. It has been a fantastic journey that we on the Board, and on behalf of the entire company, would like to express our deepest gratitude for. We see a strong CellaVision ready for the next step.
The company is in a very positive momentum with a strong international markets support organization, a progressively expanded development organization and an experienced and skilled management team that continues CellaVision's strategic journey.
The customer offering has widened considerably in recent years in addition to the 17,000 large laboratories that were previously CellaVision's market. At present, the company has a much greater potential with products for small and medium-sized laboratories comprising 100,000 laboratories and product offerings within sample preparation as a consequence of the launch of CellaVision® DC-1 and the acquisition of RAL Diagnostics,” says Sören Mellstig, Chairman of the Board.
“CellaVision is a fantastic company with fantastic colleagues and products that step by step penetrated hematology labs across the globe during the time I have been CEO. It has been a wonderfully inspiring and exciting journey that I have been able to take part in and it will undoubtedly continue in the future,” says Zlatko Rihter, CEO of CellaVision.
For further information, please contact:
Sören Mellstig, Chairman of the Board of Directors, CellaVision AB
Tel: +46 (0) 705-13 65 81 | E-mail: email@example.com
Maria Morin, VP HR & Corporate Communications, CellaVision AB
Tel: +46 (0) 709-92 62 28| E-mail: firstname.lastname@example.org
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products replace manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in sample preparation, image analysis, artificial intelligence and automated microscopy. Sales are via global partners with support from the parent company in Lund and by the company´s 18 local market support organizations covering more than 40 countries. In 2019, sales were SEK 462 million and the company's growth target is 15% per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq Stockholm, Mid Cap list. Read more at www.cellavision.com
This information constitutes information that CellaVision AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Markets Act.
The information was submitted for publication at 8:20 a.m. (CET) on May 29, 2020.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Novartis receives EC approval for Enerzair® Breezhaler®, including the first digital companion (sensor and app) that can be prescribed alongside a treatment for uncontrolled asthma in the EU7.7.2020 07:15:00 CEST | Press release
European Commission approves once-daily Enerzair®Breezhaler® (QVM149; IND/GLY/MF) in the EU, the first-in-class LABA/LAMA/ICS fixed-dose combination for patients whose asthma is uncontrolled with LABA/ICS1* Optional digital companion with sensor and app that provide inhalation confirmation, medication reminders and access to objective data to better support therapeutic decisions also covered by EC approval Approval based on robust efficacy and safety data from the Phase III IRIDIUM study, in which once-daily EnerzairBreezhaler was superior to once-daily Atectura® Breezhaler® (IND/MF) in improving the lung function of patients whose asthma is uncontrolled with LABA/ICS standard-of-care treatment2 Asthma affects an estimated 358 million people worldwide and can cause a significant personal, health and financial burden when not adequately controlled3,4 Basel, July 7, 2020 — Novartis today announced that the European Commission (EC) has approved Enerzair® Breezhaler® (QVM149; indacaterol a
NACON: NACON CONNECT IS TOMORROW, 7 JULY AT 7PM CEST6.7.2020 20:37:04 CEST | Press release
NACON CONNECT IS TOMORROW, 7 JULY AT 7PM CEST Paris (France), 6 July 2020 – NACON's first digital conference is being held tomorrow at 7PM CEST / 10AM PT on its official YouTube channel: Click here to watch NACON Connect: https://youtu.be/IL8k55zQ924 With 10 games showcased, including 4 unannounced, from a range of genres including racing, RPGs and roguelikes, this conference is essential viewing for all video game fans. NACON Check all NACON games and accessories on the new website nacongaming.com ------------------------------------------------------------------------------------------------------------------------------------------ About NACON NACON is a company of the BIGBEN Group founded in 2019 to optimize its know-how through strong synergies in the video game market. By bringing together its 8 development studios, the publishing of AA video games, the design and distribution of premium gaming devices, NACON focuses 20 years of expertise at the service of players. This new unifi
H1 2020 Financial Information6.7.2020 18:30:00 CEST | Press release
Cash and cash equivalents at €52.2m as at June 30, 2020 Daix (France), July 6, 2020 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today reported its cash position as of June 30, 2020. As of June 30, 2020, Inventiva’s cash and cash equivalents stood at €52.2 million compared to €46.9 million as of March 31, 2020 and €35.8 million as of December 31, 2019. Inventiva’s net cash flow amounted to €16.4 million in the six months ended June 30, 2020 compared to (€19.6) million in the first half of 2019. Net cash used in operating activities was (€10.7) million and (€18.7) million in the first half of 2020 and 2019, respectively. Net cash provided by (used in) financing activities was €28.1 million and (€0.1) million in the first half of 2020 and 2019, respectively. The Company believes t
Golar Power partners with Galileo and introduces Bio-LNG in Brazil6.7.2020 18:01:10 CEST | Press release
Golar Power Limited (“Golar Power”) announces today that it has signed an agreement with Galileo Technologies for the provision of LNG liquefaction solutions to support the development of its small-scale LNG distribution initiatives. The agreement between the two companies includes the introduction of a new clean fuel source through the production of Biomethane Liquefied Natural Gas (Bio-LNG). The initial order involves the provision of two LNG production clusters. The first cluster contemplates two LNG production units capable of producing 30 tons of LNG per day from a mature gas field in the Brazilian state of Bahia. The second cluster will be installed in the state of Sao Paulo, where it will capture and liquefy biomethane from landfills. This cluster will have an initial production capacity of up to 15 tons of Bio-LNG per day. Operations are expected to start in 2020. Golar Power is tapping new biomethane sources to increase the share of local LNG production and to accelerate the e
EVS Broadcast Equipment reports update of share buyback program6.7.2020 17:45:00 CEST | Press release
Publication on July 6, 2020, after market closing Regulated information – reporting share buyback EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS reports update of share buyback program EVS Broadcast Equipment reports that the following transactions, conducted within the framework of the share buyback program announced on May 6, 2020, took place between June 29, 2020 and July 3, 2020. DateNumber of shares acquiredAverage price (EUR)Highest price (EUR)Lowest price (EUR)Total (EUR)29/06/20202,500 16.0597 16.20 15.98 40,14930/06/20202,500 16.4741 16.74 16.30 41,18501/07/20202,000 16.3811 16.60 16.18 32,76202/07/20201,750 16.1656 16.22 16.08 28,29003/07/20201,500 16.3476 16.42 16.18 24,521Total10,250 16.2837 16.74 15.98 166,908 As of July 3, 2020, and since the start of the buyback program, EVS has bought 84,709 shares at an average price of EUR 15,5648, representing in total EUR 1,318,482. After aforementioned transactions the total numb
ASMI Share Buyback Update June 29 – July 3, 20206.7.2020 17:45:00 CEST | Press release
Almere, The Netherlands July 6, 2020, 5:45 p.m. CET ASMI Share Buyback Update June 29 – July 3, 2020 ASM International N.V. (Euronext Amsterdam: ASM) reports the following transactions, conducted under ASMI's current share buyback program. DateRepurchased sharesAverage priceRepurchased valueJune 29, 2020---June 30, 2020---July 1, 20201,000€ 136.00€ 136,000July 2, 2020750€ 134.45€ 100,838July 3, 2020---Total1,750€ 135.34€ 236,838 These repurchases were made as part of the €100 million share buyback program announced on June 2, 2020. Of the total program, 7.1% has been repurchased. For further details including individual transaction information please visit: www.asm.com/investors/share-information/share-buyback. About ASM International ASM International NV, headquartered in Almere, the Netherlands, its subsidiaries and participations design and manufacture equipment and materials used to produce semiconductor devices. ASM International, its subsidiaries and participations provide produc